Corcept Therapeutics (CORT) Tax Rate (2017 - 2026)
Corcept Therapeutics (CORT) reported Tax Rate of 29.07% for Q1 2026, up 14240.0% on a YoY basis from N/an in Q1 2025, and up 120.02% sequentially from 145.2% in Q4 2025.
Corcept Therapeutics (CORT) Tax Rate (2017 - 2026) Analysis & Trends
Corcept Therapeutics (CORT) has 10 years of Tax Rate data on file, last reported at 29.07% in Q1 2026.
- For the quarter ending Q1 2026, Tax Rate rose 14240.0% year-over-year to 29.07%; the trailing twelve-month figure through Mar 2026 stood at 290.77% (down 29233.0% YoY), and the FY2025 full-year result was 49.94%, down 6250.0% from the prior year.
- Tax Rate climbed to 29.07% in Q1 2026, from 145.2% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 31.61% in Q4 2022 to a low of 145.2% in Q4 2025.
- A 5-year average of 6.14% and a median of 13.86% in 2023 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate slumped 14900 bps in 2025 and soared 14240 bps in 2026, its largest moves.
- Tracing CORT's Tax Rate over 5 years: stood at 31.61% in 2022, then plunged by 53 bps to 14.72% in 2023, then slumped by 74 bps to 3.8% in 2024, then plunged by 3922 bps to 145.2% in 2025, then surged by 120 bps to 29.07% in 2026.
- Business Quant data shows CORT's Tax Rate at 29.07% in Q1 2026, 145.2% in Q4 2025, and 29.03% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Corcept Therapeutics | 10.09 Bn | 9.76 Bn | 162.02 Mn | 29.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.07% |
| Mar 31, 2026 | 29.07% |
| Mar 31, 2026 | 29.07% |
| Dec 31, 2025 | -145.20% |
| Dec 31, 2025 | -145.20% |
| Dec 31, 2025 | -145.20% |
| Sep 30, 2025 | -29.03% |
| Sep 30, 2025 | -29.03% |
| Sep 30, 2025 | -29.03% |
| Jun 30, 2025 | -10.91% |
| Jun 30, 2025 | -10.91% |
| Jun 30, 2025 | -10.91% |
| Mar 31, 2025 | -113.33% |
| Mar 31, 2025 | -113.33% |
| Mar 31, 2025 | -113.33% |
| Dec 31, 2024 | 3.80% |
| Dec 31, 2024 | 3.80% |
| Dec 31, 2024 | 3.80% |
| Sep 30, 2024 | 10.77% |
| Sep 30, 2024 | 10.77% |